Evidence map›Paper›PMID 33571420›Full record

ArticleAmerican journal of respiratory cell and molecular biology2021

IL-33-mediated Eosinophilia Protects against Acute Lung Injury.

Paulette A Krishack, Maile K Hollinger, Timothy G Kuzel, Trevor S Decker, Tyler J Louviere, Cara L Hrusch, Anne I Sperling, Philip A Verhoef

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Innate immune responses in pneumonia.Pneumonia (Nathan Qld.) · 2023
    Review
  9. Review
  10. Article
  11. Pulmonary Fibrosis and Hypereosinophilia in TLR9Pathogens (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Can Eosinophils Prevent Lung Injury? Ask PHIL.American journal of respiratory cell and molecular biology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Paulette A KrishackSection of Pulmonary and Critical Care, Department of Medicine.
Maile K HollingerSection of Pulmonary and Critical Care, Department of Medicine.
Timothy G KuzelSection of Pulmonary and Critical Care, Department of Medicine.
Trevor S DeckerSection of Pulmonary and Critical Care, Department of Medicine.
Tyler J LouviereSection of Pulmonary and Critical Care, Department of Medicine.
Cara L HruschSection of Pulmonary and Critical Care, Department of Medicine.
Anne I SperlingSection of Pulmonary and Critical Care, Department of Medicine.
Philip A VerhoefSection of Pulmonary and Critical Care, Department of Medicine.ORCID 0000-0002-1502-5468
Pulmonary and Critical Care Associates · USKaiser Permanente · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007090 · NIAID · UNIVERSITY OF CHICAGO · PI Peter Aidan Savage · 1985 to 2026
$11.7M
University of Chicago Initiative for Maximizing Student Development (IMSD) - Renewal 01R25GM109439 · NIGMS · UNIVERSITY OF CHICAGO · PI SCHWARTZ, NANCY B · 2014 to 2023
$5.7M
Functional Genomics of IL-33 Expression and Asthma RiskR01HL118758 · NHLBI · UNIVERSITY OF CHICAGO · PI NOBREGA, MARCELO A., SPERLING, ANNE I. · 2014 to 2017
$2.9M
IRF4+ respiratory dendritic cells in type 2 inflammatory responsesR01AI125644 · NIAID · UNIVERSITY OF CHICAGO · PI SPERLING, ANNE I. · 2017 to 2021
$2.1M
Type 2 Immune Responses Protect Against the Morbidity and Mortality of SepsisK08HL132109 · NHLBI · UNIVERSITY OF CHICAGO · PI VERHOEF, PHILIP A · 2016 to 2019
$656k
NCATS NIH HHS UL1 TR000430NHLBI NIH HHS K08 HL132109NHLBI NIH HHS R01 HL118758NIAID NIH HHS R01 AI125644NIAID NIH HHS T32 AI007090NIGMS NIH HHS R25 GM109439
6 · The paper itself

Abstract

Pneumonia-induced lung injury and acute respiratory distress syndrome can develop because of an inappropriate inflammatory response to acute infections, leading to a compromised alveolar barrier. Recent work suggests that hospitalized patients with allergies/asthma are less likely to die of pulmonary infections and that there is a correlation between survival from acute respiratory distress syndrome and higher eosinophil counts; thus, we hypothesized that eosinophils associated with a type 2 immune response may protect against pneumonia-induced acute lung injury. To test this hypothesis, mice were treated with the type 2-initiating cytokine IL-33 intratracheally 3 days before induction of pneumonia with airway administration of a lethal dose of

Indexed as

Acute Lung InjuryAnimalsBronchoalveolar Lavage FluidDiphtheria ToxinDisease Models, AnimalEosinophilsFemaleGene ExpressionHumansInterleukin-33Interleukin-5Leukocyte CountLeukocyte Reduction ProceduresMiceMice, Inbred C57BLMice, KnockoutDiphtheria ToxinIl33 protein, mouseInterleukin-33Interleukin-5eosinophiliaIL-33lung injuryneutrophilsStaphylococcus aureus

Identifiers

PMID33571420
PMCPMC8086044
OpenAlexW3127492715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.